• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANDA CORP PERCEVAL SUTURELESS AORTIC VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANDA CORP PERCEVAL SUTURELESS AORTIC VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS23
Device Problems Perivalvular Leak (1457); Appropriate Term/Code Not Available (3191)
Patient Problem Aortic Regurgitation (1716)
Event Date 07/21/2014
Event Type  Injury  
Manufacturer Narrative
Please note that, the other appropriate term for the device code would have been central leak.A code for the central leak is not available, for which reason code (b)(4) has been selected.A paravalvular leak was also reported, so this device code was included as well.Device location not presently known.
 
Event Description
On (b)(6) 2014, a (b)(6) female patient received a pvs23 to replace the native aortic valve.The procedure was performed in mini-thoracotomy and no concomitant procedures occurred.However, on (b)(6) 2014, the patient was re-operated due to device non-structural dysfunction with severe regurgitation (perivalvular leak 3+, central leak 3+).A new pvs23 was implanted in mini-sternotomy.The post-operative echo, performed on (b)(6) 2014, showed a good device functionality (9mmhg, no central/perivalvular leaks) and the patient was discharged a few days later.
 
Manufacturer Narrative
Based on the document review performed, no manufacturing deficiencies were identified.However, as the device was not received for analysis, no device investigation can be performed and the root cause of the reported post-operative insufficiency cannot be determined at this time.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209 s/n # (b)(4), and its stent component, were retrieved and reviewed by quality engineering at livanova.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANDA CORP
5005 north fraser way
burnaby, british columbia
MDR Report Key8241298
MDR Text Key132844897
Report Number3005687633-2019-00101
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)161020
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup,Followup
Report Date 03/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/20/2016
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient Weight77
-
-